Latest News : 2014

From left, Camillo Ricordi, M.D., Cherie Stabler, Ph.D., Ashutosh Agarwal, Ph.D., and Richard J. Cote, M.D.

$4.9 Million NIH Grant Funds “Organ on a Chip” for Diabetes Research

A trio of Miller School of Medicine investigators has received a $4.9 million grant from the National Institutes of Health for a collaborative effort to move the search for novel treatments for diabetes to a new level. The grant, one of only four awarded, is a part of the Consortium on Human Islet Biomimetics, a group under the newly formed Human Islet Research Network.

Read more »

From left, Paolo Serafini, Ph.D., Adriana de la Fuente, research assistant, and Donald T. Weed, M.D.

Cialis Shown to Benefit Head and Neck Squamous Cell Cancer Patients

Researchers at the Sylvester Comprehensive Cancer Center, in collaboration with Johns Hopkins University, have found that Tadalafil, commonly known as Cialis, can be therapeutic for certain types of cancer. When used before surgery, Tadalafil can reduce certain cells that are detrimental to head and neck squamous cell carcinoma patients’ prognoses.

Read more »

From left, Megan Baker, UM President Donna E. Shalala, Ronan T. Swords, M.D., Ph.D., Stephen D. Nimer, M.D., Pascal J. Goldschmidt, M.D.

Dr. Ronan T. Swords Receives Pap Corps Endowed Professorship in Leukemia

Ronan T. Swords, M.D., Ph.D., assistant professor of medicine and Director of the Leukemia Program at the Sylvester Comprehensive Cancer Center, has received the Pap Corps Endowed Professorship in Leukemia. The endowment comes from The Pap Corps: Champions for Cancer Research, a volunteer organization that raises money solely for cancer research at Sylvester.

Read more »

Keith A. Webster, Ph.D.

Miller School-Based Vascular Biotechnology Company Receives Start-Up Funding

In the first joint investment resulting from a novel public/private alliance, Integene International Holdings, a vascular biotechnology company led by Keith A. Webster, Ph.D., professor of molecular and cellular pharmacology and the Walter G. Ross Distinguished Chair in Vascular Biology, has received $600,000 in start-up capital.

Read more »

Rong Wen, M.D., Ph.D.

Bascom Palmer Licenses Retinal Disorder Product to Biotech Company

In a deal that may lead to the first viable treatment for retinal diseases, Amarantus Bioscience Holdings, Inc., a biotechnology company, has exercised its exclusive right to license intellectual property related to a protein product developed by a researcher at the Miller School of Medicine’s Bascom Palmer Eye Institute.

Read more »

From left, FTRP grant recipients Glen Barber, Ph.D.; Shaun Brothers, Ph.D.; Claes Wahlestedt, M.D., Ph.D.; Seung-Uon Shin, Ph.D.; and Joseph Rosenblatt, M.D.

Miller School Researchers Receive State Funding for Drug-Discovery Projects

Miller School of Medicine researchers have received three grants in the latest round of funding from the Florida Translational Research Program (FTRP), a state-funded initiative to advance drug discovery. All of the projects receiving awards focus on the discovery and development of novel small molecules for the treatment of disease, specifically cancer.

Read more »

Norma Sue Kenyon, Ph.D.

Dr. Norma Sue Kenyon Joins NIH Council of Councils

The National Institutes of Health announced the appointment of nine new members to the NIH Council of Councils, including the Miller School’s Norma Sue Kenyon, Ph.D., the Martin Kleiman Professor of Surgery, Microbiology and Immunology, and Biomedical Engineering, Chief Innovation Officer of the Miller School and Program Director of Novel Methods at the Miami Clinical and Translational Science Institute (CTSI).

Read more »

Enrique A. Mesri, Ph.D.

Sylvester/AIDS Researcher Unifies Theory on Human Viral Oncogenesis

Despite prevalence, public health importance, and the fact that virus-induced cancers are the most preventable through vaccination or anti-viral therapy, this group remains among the least understood of all cancers. A study led by Enrique A. Mesri, Ph.D., associate professor of microbiology and immunology, sheds light on this group of cancers and may help develop new targeted therapies.

Read more »

Miller School of Medicine, Schoninger Research Quadrangle

Departments Post Gains in NIH Research Grants

Reflecting the growing recognition of the University of Miami as one of the nation’s preeminent research institutions, six of the Miller School of Medicine’s departments rose in national rankings based on the size of the research grants they received from the National Institutes of Health during the 2013 federal fiscal year. The gains were especially significant in a year that saw across-the-board reductions in NIH grants.

Read more »

Geoffrey W. Stone, Ph.D.

Miller School Researchers Develop Promising Vaccine for Fighting the AIDS Virus

A research team at the University of Miami Miller School of Medicine has developed a vaccine that generates an immune system response strong enough to kill a model AIDS virus in mice. The vaccine marks a significant advance in HIV research and may lead to the development of additional new vaccines for influenza, malaria and cancer.

Read more »